文献速递皮肤肿瘤

皮肤黑色素瘤诊断后第二原发皮肤及非皮肤黑色素瘤风险:一项基于人群的研究

Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study.
PubMed 文献 · J Am Acad Dermatol · 2019-10-15

该研究基于SEER数据库的回顾性队列,纳入169,841例有皮肤黑色素瘤(CM)病史的患者,计算第二原发CM、眼、口腔及阴道/外宫颈黑色素瘤的标准化发病比(SIR)。结果显示,有CM病史者发生第二原发CM(SIR 8.17)、眼黑色素瘤(SIR 1.99)、口腔黑色素瘤(SIR 6.87)及阴道/外宫颈黑色素瘤(SIR 10.17)的风险均高于一般人群。

要点

  • 有CM病史者第二原发CM风险显著升高(SIR 8.17)。
  • 非皮肤黑色素瘤风险亦升高,包括眼、口腔及阴道/外宫颈。
  • 临床随访应同时警惕复发和第二原发CM及NCM。

核心结论

  • 有皮肤黑色素瘤病史的患者发生第二原发皮肤及非皮肤黑色素瘤的风险高于一般人群。

研究设计与样本

  • 基于SEER数据库的回顾性人群队列研究,纳入169,841例有CM病史的患者,计算SIR和超额绝对风险。

主要发现

  • 第二原发CM的SIR为8.17(95%CI 8.01-8.33)。
  • 眼黑色素瘤的SIR为1.99(95%CI 1.54-2.53)。
  • 口腔黑色素瘤的SIR为6.87(95%CI 2.23-16.04)。
  • 阴道/外宫颈黑色素瘤的SIR为10.17(95%CI 4.65-19.30)。

临床怎么用

  • 对CM病史患者,随访中除关注复发外,还应警惕第二原发CM及非皮肤黑色素瘤。

局限性

  • 癌症登记系统可能低估CM报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While cutaneous melanomas (CM) account for greater than 90% of all melanomas, noncutaneous melanomas (NCM) are more aggressive and associated with worse outcomes. The shared progenitor cell type among CM and NCM suggests that patients with a history of CM may be at higher risk for subsequent NCM. OBJECTIVE: To determine whether patients with a history of CM demonstrate an increased risk of second primary cutaneous, ocular, oral, or vaginal/exocervical melanoma compared with the general population. METHODS: This was a population-based retrospective cohort study using the Surveillance, Epidemiology, and End Results database. We calculated standardized incidence ratios (SIRs) and excess absolute risks of second primary cutaneous, ocular, oral, and vaginal/exocervical melanoma in patients with a history of CM. RESULTS: Patients with prior CM (n = 169,841) were more likely than the general population to develop a second primary CM (SIR, 8.17; 95% confidence interval [CI], 8.01-8.33), ocular melanoma (SIR, 1.99; 95% CI, 1.54-2.53), oral melanoma (SIR, 6.87; 95% CI, 2.23-16.04), and vaginal/exocervical melanoma (SIR, 10.17; 95% CI, 4.65-19.30). LIMITATIONS: This study is limited by possible under-reporting of CM in cancer registries. CONCLUSION: In caring for patients with a history of CM, physicians should be vigilant not only about risk of recurrence but also about second primary CM and NCM.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Beroukhim K, Pourang A, Eisen DB, et al. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study. J Am Acad Dermatol. 2019. PMID: 31626886. doi:10.1016/j.jaad.2019.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。